global healthcare – The Milli Chronicle

Monday, April 27, 2026

Latest:

Factual Version of a Story

NewsDesk MC April 27, 2026April 27, 2026 $11.75 billion deal, biosimilars, branded drugs, corporate acquisition, dermatology, emerging markets, global healthcare, healthcare business, India pharma deal, Indian pharmaceutical industry, mergers and acquisitions, Mumbai, obesity drugs, oncology, Organon, pharma expansion, pharmaceutical acquisition, specialty medicines, Sun Pharma, U.S. drugmaker, Women’s Health

Sun Pharma Strikes $11.75 Billion Organon Deal in India’s Biggest Pharma Acquisition

Mumbai — Sun Pharmaceutical Industries will acquire U.S.-based drugmaker Organon & Co in an all-cash deal valued at about $11.75

Asia Latest News

NewsDesk MC November 7, 2025 active pharmaceutical ingredients, API demand, API exports, API manufacturing, API production growth., biotechnology India, CDMO services, contract manufacturing, diabetes drugs, Divi’s Laboratories, Divi’s profits, drug manufacturing, Eli Lilly, European pharma, global healthcare, global pharma supply chain, Hyderabad pharma company, India drugmakers, Indian pharmaceutical exports, Novo Nordisk, pharma growth India, pharma industry trends, pharma investment, pharmaceutical innovation, pharmaceutical R&D, sustainable manufacturing, US market pharma, weight-loss drugs

Divi’s Laboratories Reports Strong Q2 Growth, Driven by Rising API Demand and Global Expansion

Hyderabad – Indian pharmaceutical giant Divi’s Laboratories outperforms expectations with a surge in profits and strong export performance amid growing

Asia Featured News

NewsDesk MC November 5, 2025 anti-retroviral drugs, Aurobindo Pharma, Aurobindo profit growth, drug industry trends, generic drugs, global healthcare, healthcare development, healthcare growth, HIV treatment, India pharma news, Indian drugmakers, Indian pharma companies., Indian pharmaceutical industry, medicine manufacturing, North America pharma market, pharma innovation, pharma profits, pharma sector India, pharmaceutical exports, pharmaceutical growth

Aurobindo Pharma Reports Steady Profit Growth Driven by Domestic and Global Demand

Aurobindo Pharma has reported a rise in profit for the second quarter of the financial year, reflecting steady domestic demand

Featured

NewsDesk MC October 26, 2025October 27, 2025 American Medical Association, Conrad Waiver, cross-border medicine, global healthcare, global medical workforce, H-1B visa policy, healthcare immigration news, immigrant physicians, Indian doctors in America, Indian-origin doctors, international cooperation in healthcare., international doctors, rural healthcare access, rural hospitals, U.S. doctor shortage

Indian Doctors Keep Rural America’s Heart Beating as Visa Policy Debate Unfolds

He believes policymakers understand that international doctors are not replacing U.S. graduates — they are filling essential gaps. In the